BioVaxys in Non-Binding Discussions for Major Immunotherapeutics Technology Acquisition

VANCOUVER, BC, Dec. 13, 2023 /PRNewswire/ — BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB)...

Read More